Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-112087
Filing Date
2022-10-28
Accepted
2022-10-27 19:09:21
Documents
6
Effectiveness Date
2022-10-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2228593d1_s8.htm S-8 81066
2 EXHIBIT 4.2 tm2228593d1_ex4-2.htm EX-4.2 78681
3 EXHIBIT 5.1 tm2228593d1_ex5-1.htm EX-5.1 10414
4 EXHIBIT 23.2 tm2228593d1_ex23-2.htm EX-23.2 2686
5 EX-FILING FEES tm2228593d1_ex-filingfees.htm EX-FILING FEES 18748
6 GRAPHIC tm2228593d1_ex5-1img001.jpg GRAPHIC 11887
  Complete submission text file 0001104659-22-112087.txt   209129
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268034 | Film No.: 221338673
SIC: 2834 Pharmaceutical Preparations